Skip to main content
SpringerLink
Log in

Surgical Trials for Gastric Cancer

  • Chapter
  • First Online:
Gastric Cancer

  • 2624 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg. 1988;75(2):110–2.

    Article  CAS  PubMed  Google Scholar 

  2. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79(9–10):1522–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Degiuli M. Survival of early gastric cancer in a specialized European center. Which lymphadenectomy is necessary? World J Surg. 2006;30(12):2193–2203.

    Article  PubMed  Google Scholar 

  4. Degiuli M, Sasako M, Ponti A, et al. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer. 2004;90(9):1727–32.

    CAS  PubMed Central  PubMed  Google Scholar 

  5. Degiuli M, Sasako M, Ponti A, et al. Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian gastric cancer study group prospective multicenter surgical study. J Clin Oncol. 1998;16(4):1490–3.

    CAS  PubMed  Google Scholar 

  6. Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7(4):309–15.

    Article  CAS  PubMed  Google Scholar 

  7. Bonenkamp JJ, Songun I, Hermans J, et al. randomized comparison of morbidity after D1 and D2 dissection for gastric-cancer in 996 Dutch patients. Lancet. 1995; 345(8952):745–8.

    Article  CAS  PubMed  Google Scholar 

  8. Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg. 1994;220(2):176–82.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Songun I, Putter H, Kranenbarg EM-K, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439–49.

    Article  PubMed  Google Scholar 

  10. Memon MA, Subramanya MS, Khan S, et al. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg. 2011;253(5):900–11.

    Article  PubMed  Google Scholar 

  11. Lustosa SA, Saconato H, Atallah AN, et al. Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials. Acta Cir Bras. 2008;23(6):520–30.

    Article  PubMed  Google Scholar 

  12. McCulloch P, Niita ME, Kazi H, et al. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg. 2005;92(1):5–13.

    Article  CAS  PubMed  Google Scholar 

  13. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.

    Article  CAS  PubMed  Google Scholar 

  14. Yonemura Y, Wu CC, Fukushima N, et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol. 2008;13(2):132–7.

    Article  PubMed  Google Scholar 

  15. Kulig J, Popiela T, Kolodziejczyk P, et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg. 2007;193(1):10–5.

    Article  PubMed  Google Scholar 

  16. Wang Z, Chen JQ, Cao YF. Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer. World J Gastroenterol. 2010;16(9):1138–49.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Kolovou GD, Anagnostopoulou KK, Salpea KD, et al. The prevalence of metabolic syndrome in various populations. Am J Med Sci. 2007;333(6):362–71.

    Article  PubMed  Google Scholar 

  18. Bunt AM, Hermans J, Boon MC, et al. Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer. J Clin Oncol. 1994;12(2):417–22.

    CAS  PubMed  Google Scholar 

  19. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312(25):1604–8.

    Article  CAS  PubMed  Google Scholar 

  20. Hamashima C, Saito H, Nakayama T, et al. The standardized development method of the Japanese guidelines for cancer screening. Jpn J Clin Oncol. 2008;38(4):288–95.

    Article  PubMed  Google Scholar 

  21. Lee KS, Oh DK, Han MA, et al. Gastric cancer screening in Korea: report on the national cancer screening program in 2008. Cancer Res Treat. 2011;43(2):83–8.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Moehler M, Al-Batran SE, Andus T, et al. German S3-guideline “diagnosis and treatment of esophagogastric cancer”. Z Gastroenterol. 2011;49(4):461–531.

    Article  CAS  PubMed  Google Scholar 

  23. Imamura H, Kurokawa Y, Kawada J, et al. Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial. World J Surg. 2011;35(3):625–30.

    Article  PubMed  Google Scholar 

  24. Fujita J, Kurokawa Y, Sugimoto T, et al. Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer. 2012;15(1):42–8.

    Article  PubMed  Google Scholar 

  25. Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg. 2006;93(5):559–63.

    Article  CAS  PubMed  Google Scholar 

  26. Miyashiro I, Hiratsuka M, Sasako M, et al. High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302. Gastric Cancer. 2014;17(2):316–23.

    Article  PubMed  Google Scholar 

  27. Kitagawa Y, Takeuchi H, Takagi Y, et al. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol. 2013;31(29):3704–10.

    Article  PubMed  Google Scholar 

  28. Kitano S, Iso Y, Moriyama M, et al. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4(2):146–8.

    CAS  Google Scholar 

  29. Kitano S, Shiraishi N, Fujii K, et al. A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report. Surgery. 2002;131(1 Suppl):306–11.

    Article  Google Scholar 

  30. Lee JH, Han HS, Lee JH. A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results. Surg Endosc. 2005;19(2):168–73.

    Article  PubMed  Google Scholar 

  31. Huscher CG, Mingoli A, Sgarzini G, et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg. 2005;241(2):232–7.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Kim YW, Baik YH, Yun YH, et al. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg. 2008;248(5):721–7.

    Article  PubMed  Google Scholar 

  33. Kim YW, Yoon HM, Yun YH, et al. Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301). Surg Endosc. 2013;27(11):4267–76.

    Article  PubMed  Google Scholar 

  34. Kim HH, Hyung WJ, Cho GS, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report—a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg. 2010;251(3):417–20.

    Article  PubMed  Google Scholar 

  35. Nakamura K, Katai H, Mizusawa J, et al. A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer (JCOG0912). Jpn J Clin Oncol. 2013;43(3):324–7.

    Article  PubMed  Google Scholar 

  36. Cai J, Wei D, Gao CF, et al. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer. Dig Surg. 2011;28(5–6):331–7.

    Article  CAS  PubMed  Google Scholar 

  37. Lee JH, Son SY, Lee CM, et al. Morbidity and mortality after laparoscopic gastrectomy for advanced gastric cancer: results of a phase II clinical trial. Surg Endosc. 2013;27(8):2877–85.

    Article  PubMed  Google Scholar 

  38. Yoshikawa T, Fukunaga T, Taguri M, et al. Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for operable gastric cancer, a randomized phase II trial (LANDSCOPE trial). Jpn J Clin Oncol. 2012;42(7):654–7.

    Article  PubMed  Google Scholar 

  39. Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst. 1997;89(7):480–7.

    Article  CAS  PubMed  Google Scholar 

  40. Sugarbaker PH, Mora JT, Carmignani P, et al. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist. 2005;10(2):112–22.

    Article  CAS  PubMed  Google Scholar 

  41. Markman M, Kennedy A, Webster K, et al. Paclitaxel administration to gynecologic cancer patients with major cardiac risk factors. J Clin Oncol. 1998;16(11):3483–5.

    CAS  PubMed  Google Scholar 

  42. Kodera Y, Imano M, Yoshikawa T, et al. A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial). Jpn J Clin Oncol. 2011;41(2):283–6.

    Article  PubMed  Google Scholar 

  43. Kuramoto M, Shimada S, Ikeshima S, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg. 2009;250(2):242–6.

    Article  PubMed  Google Scholar 

  44. Misawa K, Mochizuki Y, Ohashi N, et al. A randomized phase III trial exploring the prognostic value of extensive intraoperative peritoneal lavage in addition to standard treatment for resectable advanced gastric cancer: CCOG 1102 study. Jpn J Clin Oncol. 2014;44(1):101–3.

    Article  PubMed  Google Scholar 

  45. Strohlein MA, Lordick F, Ruttinger D, et al. Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial. Onkologie. 2011;34(3):101–8.

    Article  PubMed  Google Scholar 

  46. Went P, Vasei M, Bubendorf L, et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer. 2006;94(1):128–35.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Riesenberg R, Buchner A, Pohla H, et al. Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM × alpha CD3). J Histochem Cytochem. 2001;49(7):911–7.

    Article  CAS  PubMed  Google Scholar 

  48. Ruf P, Lindhofer H. Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody. Blood. 2001;98(8):2526–34.

    Article  CAS  PubMed  Google Scholar 

  49. Heiss MM, Murawa P, Koralewski P, et al. The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial. Int J Cancer. 2010;127(9):2209–21.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Goere D, Gras-Chaput N, Auperin A, et al. Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab. BMC Cancer. 2014;14:148.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575–81.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Kerkar SP, Kemp CD, Duffy A, et al. The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials. 2009;10:121.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Glehen O, Passot G, Villeneuve L, et al. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer. 2014;14:183.

    Article  PubMed Central  PubMed  Google Scholar 

  54. Gertler R, Rosenberg R, Feith M, et al. Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review. Am J Gastroenterol. 2009;104(11):2838–51.

    Article  PubMed  Google Scholar 

  55. Ikeguchi M, Kuroda H, Saito H, et al. A new pouch reconstruction method after total gastrectomy (pouch-double tract method) improved the postoperative quality of life of patients with gastric cancer. Langenbecks Arch Surg. 2011;396(6):777–81.

    Article  PubMed  Google Scholar 

  56. Iwahashi M, Nakamori M, Nakamura M, et al. Evaluation of double tract reconstruction after total gastrectomy in patients with gastric cancer: prospective randomized controlled trial. World J Surg. 2009;33(9):1882–8.

    Article  PubMed  Google Scholar 

  57. Tsujimoto H, Sakamoto N, Ichikura T, et al. Optimal size of jejunal pouch as a reservoir after total gastrectomy: a single-center prospective randomized study. J Gastrointest Surg. 2011;15(10):1777–82.

    Article  PubMed  Google Scholar 

  58. Yoo CH, Sohn BH, Han WK, et al. Proximal gastrectomy reconstructed by jejunal pouch interposition for upper third gastric cancer: prospective randomized study. World J Surg. 2005;29(12):1592–9.

    Article  PubMed  Google Scholar 

  59. Iwata T, Kurita N, Ikemoto T, et al. Evaluation of reconstruction after proximal gastrectomy: prospective comparative study of jejunal interposition and jejunal pouch interposition. Hepatogastroenterology. 2006;53(68):301–3.

    PubMed  Google Scholar 

  60. Takagawa R, Kunisaki C, Kimura J, et al. A pilot study comparing jejunal pouch and jejunal interposition reconstruction after proximal gastrectomy. Dig Surg. 2010;27(6):502–8.

    Article  PubMed  Google Scholar 

  61. Ishikawa M, Kitayama J, Kaizaki S, et al. Prospective randomized trial comparing Billroth I and Roux-en-Y procedures after distal gastrectomy for gastric carcinoma. World J Surg. 2005;29(11):1415–20; (discussion 1421).

    Article  PubMed  Google Scholar 

  62. Takiguchi S, Yamamoto K, Hirao M, et al. A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer. 2012;15(2):198–205.

    Article  PubMed  Google Scholar 

  63. Imamura H, Takiguchi S, Yamamoto K, et al. Morbidity and mortality results from a prospective randomized controlled trial comparing Billroth I and Roux-en-Y reconstructive procedures after distal gastrectomy for gastric cancer. World J Surg. 2012;36(3):632–7.

    Article  PubMed  Google Scholar 

  64. Hirao M, Takiguchi S, Imamura H, et al. Comparison of Billroth I and Roux-en-Y reconstruction after distal gastrectomy for gastric cancer: one-year postoperative effects assessed by a multi-institutional RCT. Ann Surg Oncol. 2013;20(5):1591–7.

    Article  PubMed  Google Scholar 

  65. Lee MS, Ahn SH, Lee JH, et al. What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc. 2012;26(6):1539–47.

    Article  PubMed  Google Scholar 

  66. Kim J, Lee J, Hyung WJ, et al. Gastric cancer surgery without drains: a prospective randomized trial. J Gastrointest Surg. 2004;8(6):727–32.

    Article  PubMed  Google Scholar 

  67. Alvarez Uslar R, Molina H, Torres O, et al. Total gastrectomy with or without abdominal drains. A prospective randomized trial. Rev Esp Enferm Dig. 2005;97(8):562–9.

    Article  CAS  PubMed  Google Scholar 

  68. Doglietto GB, Papa V, Tortorelli AP, et al. Nasojejunal tube placement after total gastrectomy: a multicenter prospective randomized trial. Arch Surg. 2004;139(12):1309–13; (discussion 1313).

    Article  PubMed  Google Scholar 

  69. Li C, Mei JW, Yan M, et al. Nasogastric decompression for radical gastrectomy for gastric cancer: a prospective randomized controlled study. Dig Surg. 2011;28(3):167–72.

    Article  PubMed  Google Scholar 

  70. Mohri Y, Tonouchi H, Kobayashi M, et al. Randomized clinical trial of single- versus multiple-dose antimicrobial prophylaxis in gastric cancer surgery. Br J Surg. 2007;94(6):683–8.

    Article  CAS  PubMed  Google Scholar 

  71. Haga N, Ishida H, Ishiguro T, et al. A prospective randomized study to assess the optimal duration of intravenous antimicrobial prophylaxis in elective gastric cancer surgery. Int Surg. 2012;97(2):169–76.

    Article  PubMed Central  PubMed  Google Scholar 

  72. Imamura H, Kurokawa Y, Tsujinaka T, et al. Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery: a phase 3, open-label, randomised controlled, non-inferiority trial. Lancet Infect Dis. 2012;12(5):381–7.

    Article  CAS  PubMed  Google Scholar 

  73. Sultan J, Griffin SM, Di Franco F, et al. Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg. 2012;99(3):346–55.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  74. Fujitani K, Tsujinaka T, Fujita J, et al. Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer. Br J Surg. 2012;99(5):621–9.

    Article  CAS  PubMed  Google Scholar 

  75. Zhao H, Zhao H, Wang Y, et al. Randomized clinical trial of arginine-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing gastric cancer surgery. J Cancer Res Clin Oncol. 2013;139(9):1465–70.

    Article  CAS  PubMed  Google Scholar 

  76. Marano L, Porfidia R, Pezzella M, et al. Clinical and immunological impact of early postoperative enteral immunonutrition after total gastrectomy in gastric cancer patients: a prospective randomized study. Ann Surg Oncol. 2013;20(12):3912–8.

    Article  PubMed  Google Scholar 

  77. Adachi S, Takiguchi S, Okada K, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 2010;138(4):1312–20.

    Article  CAS  PubMed  Google Scholar 

  78. Zhu Z, Wang C, Xu C, et al. Influence of patient-controlled epidural analgesia versus patient-controlled intravenous analgesia on postoperative pain control and recovery after gastrectomy for gastric cancer: a prospective randomized trial. Gastric Cancer. 2013;16(2):193–200.

    Article  CAS  PubMed  Google Scholar 

  79. Schietroma M, Cecilia EM, Carlei F, et al. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double-blind, controlled, single-center trial. Ann Surg Oncol. 2013;20(5):1584–90.

    Article  PubMed  Google Scholar 

  80. Bernini M, Bencini L, Sacchetti R, et al. The cholegas study: safety of prophylactic cholecystectomy during gastrectomy for cancer: preliminary results of a multicentric randomized clinical trial. Gastric Cancer. 2013;16(3):370–6.

    Article  PubMed  Google Scholar 

  81. Wang D, Kong Y, Zhong B, et al. Fast-track surgery improves postoperative recovery in patients with gastric cancer: a randomized comparison with conventional postoperative care. J Gastrointest Surg. 2010;14(4):620–7.

    Article  PubMed  Google Scholar 

  82. Chen Hu J, Xin Jiang L, Cai L, et al. Preliminary experience of fast-track surgery combined with laparoscopy-assisted radical distal gastrectomy for gastric cancer. J Gastrointest Surg. 2012;16(10):1830–9.

    Article  PubMed  Google Scholar 

  83. Kim JW, Kim WS, Cheong JH, et al. Safety and efficacy of fast-track surgery in laparoscopic distal gastrectomy for gastric cancer: a randomized clinical trial. World J Surg. 2012;36(12):2879–87.

    Article  PubMed  Google Scholar 

  84. Feng F, Ji G, Li JP, et al. Fast-track surgery could improve postoperative recovery in radical total gastrectomy patients. World J Gastroenterol. 2013;19(23):3642–8.

    Article  PubMed Central  PubMed  Google Scholar 

  85. Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7(8):644–51.

    Article  PubMed  Google Scholar 

  86. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246(6):992–1000; (discussion 1000–1).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Surgical Trials (CHIRNET TUM), Technical University of Munich, Munich, Germany

    Daniel Reim MD

  2. Department of Surgery, Klinikum Rechts der Isar, Munich, Germany

    Alexander Novotny MD

  3. Clinical Operations, European Clinical Research Infrastructure Network (ECRIN), 5-7 rue Watt, 75013, Paris, France

    Christoph Schuhmacher MD

Authors
  1. Daniel Reim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander Novotny MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christoph Schuhmacher MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Schuhmacher MD .

Editor information

Editors and Affiliations

  1. Gastric and Mixed Tumor Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Vivian E. Strong

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Reim, D., Novotny, A., Schuhmacher, C. (2015). Surgical Trials for Gastric Cancer. In: Strong, V. (eds) Gastric Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-15826-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15826-6_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15825-9

  • Online ISBN: 978-3-319-15826-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation